Generic drug company Mylan rejected for the second time Monday a $40.1 billion takeover offer from Israeli pharmaceutical power Teva, just days after Mylan's own bid for rival Perrigo was rebuffed.
9 hours ago
The Food and Drug Administration says Medtronic must stop most sales of its implantable drug pumps after years of uncorrected problems.
2 hours ago
- Pages: 1